London Institutes Create Personalized Clinical Lung Cancer Program | GenomeWeb

NEW YORK (GenomeWeb News) – A collection of London research institutes and hospitals have banded together to launch an initiative to develop genetically tailored treatments for thousands of lung cancer patients, the Institute for Cancer Research said today.

The partners involved in the new London Lung Cancer Alliance plan to use tumor sequencing and genetic testing to personalize treatments for up to 3,000 lung cancer patients a year in London and in five other cities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.